S 2326
116th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Drug therapy
Government information and archives
Health care costs and insurance
Health care coverage and access
Health technology, devices, supplies
Manufacturing
Medicare
Public participation and lobbying
NOVEL Act of 2019
Introduced: July 30, 2019
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 30, 2019
Read twice and referred to the Committee on Finance.
Jul 30, 2019
Introduced in Senate
Plain-English summary
New Opportunities for Value that Extend Lives Act of 2019 or the NOVEL Act of 2019
This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1